Type-specific risk factors and outcome in an outbreak with 2 different clostridium difficile types simultaneously in 1 hospital

Clinical Infectious Diseases

Volumn 53, Issue 9, 2011, Pages 860-869

  Goorhuis, A ^a   Debast, S B ^b   Dutilh, J C ^c   Van Kinschot, C M ^a   Harmanus, C ^a   Cannegieter, S C ^a   Hagen, E C ^c   Kuijper, E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Medical Microbiology ^*  (Netherlands)

^c MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; CLINDAMYCIN; IMMUNOSUPPRESSIVE AGENT; QUINOLONE DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; EPIDEMIC; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; STOMACH INTUBATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RIBOTYPING; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054082057     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir549     Document Type: Article

References (29)

1. Goorhuis A, van der Kooi T, Vaessen N, et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in the Netherlands. Clin Infect Dis 2007; 45:695-703. (Pubitemid 47378882)
2. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-9. (Pubitemid 41770165)
3. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433-41. (Pubitemid 41770164)
4. Pépin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173:1037-42.
5. Warny M, Pépin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366:1079-84. (Pubitemid 41338761)
6. Alfa MJ, Kabani A, Lyerly D, et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000; 38:2706-14. (Pubitemid 30485154)
7. Drudy D, Fanning S, Kyne L. Toxin A-negative, toxin B-positive Clostridium difficile. Int J Infect Dis 2007; 11:5-10. (Pubitemid 44937660)
8. Goorhuis A, LegariaMC, van den Berg RJ, et al. Application of multiplelocus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficilein a general hospital in Buenos Aires, Argentina. Clin Microbiol Infect 2009; 15:1080-6.
9. Kikkawa H, Hitomi S, Watanabe M. Prevalence of toxin A-nonproducing/toxin B-producing Clostridium difficile in the Tsukuba-Tsuchiura district, Japan. J Infect Chemother 2007; 13:35-8. (Pubitemid 46356241)
10. Kim H, Riley TV, Kim M, et al. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: Impact on laboratory diagnosis. J Clin Microbiol 2008; 46: 1116-7. (Pubitemid 351380012)
11. Kuijper EJ, de Weerdt J, Kato H, et al. Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 2001; 20:528-34. (Pubitemid 32905528)
12. Pituch H, van den Braak N, van Leeuwen W, et al. Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland. Clin Microbiol Infect 2001; 7:442-6. (Pubitemid 34960337)
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-83. (Pubitemid 17055592)
14. van den Berg RJ, Bruijnesteijn van Coppenraet LS, Gerritsen HJ, et al. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol 2005; 43:5338-40. (Pubitemid 41484054)
15. Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, van der Vorm ER, Kuijper EJ. Characteristics and incidence of Clostridium difficileassociated disease in the Netherlands, 2005. Clin Microbiol Infect 2007; 13:1058-64. (Pubitemid 47543105)
16. Bidet P, Lalande V, Salauze B, et al. Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 2000; 38:2484-7. (Pubitemid 30487377)
17. Barbut F, Mastrantonio P, Delmée M, Brazier J, Kuijper E, Poxton I. European Study Group on Clostridium difficile (ESGCD). Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 2007; 13:1048-57. (Pubitemid 47553515)
18. Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47:1162-70.
19. Marsh JW, O'Leary MM, Shutt KA, et al. Multilocus variablenumber tandem-repeat analysis for investigation of Clostridium difficile transmission in hospitals. J Clin Microbiol 2006; 44: 2558-66. (Pubitemid 44092427)
20. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136:834-44. (Pubitemid 34568654)
21. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ 2004; 171:51-8. (Pubitemid 38925121)
22. Bartlett JG. Narrative review: The new epidemic of Clostridium difficileassociated enteric disease. Ann Intern Med 2006; 145:758-64. (Pubitemid 351650356)
23. McFee RB, Abdelsayed GG. Clostridium difficile. Dis Mon 2009; 55: 439-70.
24. Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: Patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010; 50:194-201.
25. Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol 2009; 7:868-73. e2.
26. MacCannell DR, Louie TJ, Gregson DB, et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J Clin Microbiol 2006; 44:2147-52. (Pubitemid 43902167)
27. Oake N, Taljaard M, van Walraven C, Wilson K, Roth V, Forster AJ. The effect of hospital-acquired Clostridium difficile infection on inhospital mortality. Arch Intern Med 2010; 170:1804-10.
28. Forgetta V, Oughton MT, Marquis P, et al. A fourteen-genome comparison identifies DNA markers for severe disease-associated strains of Clostridium difficile. J Clin Microbiol 2011; 49:2230-8.
29. Rothman KJ, Greenland S, Lash TL. Modern epidemiology, 3rd ed. Philadelphia, Pennsylvania: Lippincott, Williams, & Wilkins, 2008.